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Missense mutations at protein–protein interaction sites, called interfaces, are important contributors to human
disease. Interfaces are non-uniform surface areas characterized by two main regions, “core” and “rim”, which
differ in terms of evolutionary conservation and physicochemical properties. Moreover, within interfaces, only
a small subset of residues (“hot spots”) is crucial for the binding free energy of the protein–protein complex.
We performed a large-scale structural analysis of human single amino acid variations (SAVs) and
demonstrated that disease-causing mutations are preferentially located within the interface core, as opposed
to the rim (p b 0.01). In contrast, the interface rim is significantly enriched in polymorphisms, similar to the
remaining non-interacting surface. Energetic hot spots tend to be enriched in disease-causing mutations
compared to non-hot spots (p = 0.05), regardless of their occurrence in core or rim residues. For individual amino
acids, the frequency of substitution into a polymorphismor disease-causingmutation differed to other amino acids
and was related to its structural location, as was the type of physicochemical change introduced by the SAV.
In conclusion, this study demonstrated the different distribution and properties of disease-causing SAVs and
polymorphisms within different structural regions and in relation to the energetic contribution of amino acid in
protein–protein interfaces, thus highlighting the importance of a structural system biology approach for predicting
the effect of SAVs.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Introduction
With more than a million individual-specific DNA
variations identified in the human genome, deriving
insights from the large quantity of data generated by
genome-wide association studies, individual whole
genome sequencing and, in the near future, the
100,000 genomes project are a major challenge.
Protein–protein interactions (PPIs) are central in
all biological processes and understanding how
PPIs contribute to human disease is essential. As
proteins do not function in isolation but interact in
complex biological networks, single amino acid
variations (SAVs) occurring at protein interfaces
can profoundly disrupt not just a single protein but an
entire biological pathway. Protein–protein recogni-uthors. Published by Elsevier Ltd. This is an
rg/licenses/by/4.0/).tion and interaction occurs in specific areas of the
protein surface, known as protein interfaces. We
previously showed that protein interfaces are
enriched in disease-causing missense mutations
compared to other protein surface regions [1], a
finding that was confirmed by others [2,3]. The
important contribution of amino acid changes occur-
ring at protein interfaces to human disease has
recently been corroborated by studies showing that
mutations causing cancer occur at protein interac-
tion sites more often than they occur on the rest of
the protein surface [4]. Mutations can disrupt a
protein interface by modifying its physicochemical,
structural and energetic characteristics [3,5–7]. Teng
et al. recently studied a large set of protein
complexes and showed that disease-causingopen access article under the CC BY license
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2887Missense Mutations and Protein–Protein Interfacesmutations occurring at protein interfaces tend to alter
the free binding energy of the complex, compared to
harmless SAVs [8].
A protein interface is a complex, non-uniform area
located on the protein surface. PPI occurs through
interactions between residues on two opposite
interfaces [9,10]. Although a protein interface can
occupy a large area, only a small subset of its
residues plays a crucial role in the binding free
energy of the complex. These few key residues are
known as energetic “hot spots” [11–13] and are
typically identified in vitro and in silico as those
residues that cause a ≥2 kcal/mol reduction in
binding free energy when mutated to alanine [12].
The characteristics of hot spots have been
extensively studied. It has been shown that they
are enriched in arginine, tryptophan and tyrosine and
they overlap to a large extent with interface “core”
residues [14]. Interface core residues become
solvent inaccessible upon PPI, as opposed to
interface “rim” residues that remain partially solvent
accessible [15,16]. The interface core and rim differ
not only in their energetic contribution to the complex
stability but also in terms of their physicochemical
and evolutionary characteristics. Interface core
residues tend to be evolutionarily more conserved
and their side chains often display less mobility upon
binding, compared to rim residues [17,18]. A more
complex partition of the interface proposed by Levy
identifies a third region called support, which amino
acid composition resembles that of the protein buried
(interior) region [19].
Despite the clear distinctive functional importance
of core and rim residues, as well as that of energetic
hot spots versus less energetically important resi-Fig. 1. Schematic diagram of core and rim interface regions
interface. Interacting proteins are presented in light and dark g
and the rim is presented in blue.dues, the individual contribution of core and hot spot
residues to human disease remains largely unex-
plored. One could expect to see rare disease-causing
mutations and common polymorphisms differentially
distributed between interface residues. Moreover,
disease-causing mutations are expected to have a
greater impact on protein structure, function and
protein complex thermodynamics when occurring in
core residues or in energetic hot spots.
In this study, we performed a systematic analysis
of the distribution and properties of naturally occur-
ring polymorphisms and disease-causing SAVs
within interface core and rim residues and compared
these findings to those obtained from SAVs localized
on the remaining protein structure. Moreover, we
analyzed the effect of polymorphisms and disease-
causing SAVs on the complex binding free energy.Results
SAVs are differentially distributed according to
their location within the interface
A total of 3282 disease-causing SAVs and 1699
polymorphisms occurring in 705 proteins were
analyzed. A total of 62.6% of all SAVs (disease
and polymorphisms) occurred in solvent-accessi-
ble residues, which comprise interacting (interface)
and non-interacting (surface) amino acids. Within
disease-causing SAVs, 54.5% (1788 SAVs) occurred
in solvent-accessible residues, of which 466 were
located on the protein interface (215 in the core and
251 in the rim) and1322were locatedon the remainingInterface
core 
Interface
rim 
Interface
rim 
. Highlighted is a cross-sectional view of a protein–protein
ray, respectively. The interface core is presented in orange
2888 Missense Mutations and Protein–Protein Interfacesprotein surface. Disease-causing SAVs were 35%
more likely to occur at interfaces compared to
non-interacting surfaces (OR 1.35, 95% CI 1.22–
1.51, p b 0.0001) but were 39% less likely to occur in
interface than in buried residues (OR 0.61, 95% CI
0.55–0.67, p b 0.0001), in keepingwith earlier work by
David et al. [1]. To provide a structural relationship
between protein interface anatomy and human
genetic variations, we divided the interface in core
and rim (Fig. 1). Disease-causing SAVs were 49%
more likely to occur in the interface core rather than the
rim and were 72%more likely to occur in the interface
core than in the non-interacting protein surface
(Table 1), thus clearly demonstrating a different
contribution of core and rim regions to human disease.
Moreover, disease-causing SAVs were not preferen-
tially located at the interface rim rather than the
remaining non-interacting surface.
When polymorphism location was analyzed,
78.7% of polymorphisms resided within surface-
accessible residues (241 in interface residues and
1096 in surface non-interface residues). Polymor-
phisms were less likely to be located in the interface
core compared to the rim (p b 0.003) or the rest of
the non-interacting surface (p b 0.0002). No differ-
ence was detected in the frequency of polymor-
phisms between the interface rim and the rest of the
non-interacting surface (p = 0.65).
The results of our previous study [1] suggested
that the interacting and non-interacting surface had
similar enrichment in polymorphisms, which ap-
peared to be in contrast to the interface enrichment
in disease-causing SAVs. Dividing the interface in
core and rim demonstrated that the enrichment in
polymorphisms is in the rim and not in the core. The
interface rim and the non-interacting surface areTable 1. Odds ratio for disease-causing SAVs and polymorph
Disease-causing
SAVs
Total
residues
Observed Expected O/E
Buried 72467 1494 947.05 1.58 Burie
Core 13486 215 176.24 1.22 Core
Rim 23478 251 306.83 0.82 Core
Surface 141704 1322 1851.88 0.71 Core
Total 251135 3282 Rim
Rim
Polymorphisms Total
residues
Observed Expected O/E
Buried 72467 362 490.26 0.74 Burie
Core 13486 66 91.24 0.72 Core
Rim 23478 175 158.84 1.10 Core
Surface 141704 1096 958.67 1.14 Core
Total 251135 1699 Rim
Rim
Core, interface core; rim, interface rim; O/E, observed/expected; OR, o
p-value; adjusted p-value, Bonferroni adjusted p-values. Surface, noncharacterized by lower evolutionary conservation
[17] and more side-chain flexibility [18] compared to
the interface core and the protein buried regions,
thus explaining why the interface rim and the
non-interacting surface have a greater ability to
accommodate amino acid changes.
In silico prediction of disease-causing SAVs and
polymorphisms varies across different protein
regions
Residue conservation and the physicochemical
characteristics of disease-causing SAVs and poly-
morphisms occurring in different protein regions
were analyzed using BLOSUM62 and Grantham
matrices and SIFT (Sorting Tolerant From Intolerant).
BLOSUM62 and Grantham matrices score substitu-
tions are based on multiple sequence alignment and
physicochemical changes from the wild type, respec-
tively. Both methods showed that the majority of
disease-causing SAV scores were compatible with a
deleterious effect. Moreover, when the effect of
disease-causing SAV was analyzed, both matrices
showed that the number of SAV identified as delete-
riouswas significantly greater for disease-causing SAV
located on the non-interacting surface compared to
SAVs located in any other protein region (Bonferroni-
corrected p value of b0.05, χ2 test; Fig. 2). Surface
residues are less evolutionarily conserved and not
under the constraint of tight interior packing and
restricted conformational space, as in the case of
buried residues, and can, therefore, accommodate
larger physicochemical changes compared to buried
and interface core residues. In contrast, buried and
interface residues have highly specialized roles and
subtle changes in size or physicochemical propertiesisms according to protein structure location.
OR 95% C.I. p-Value Adjusted
p value
d versus Surface 2.24 2.08 – 2.40 b0.00001 b0.00001
versus Buried 0.77 0.67 – 0.89 0.0004 0.002
versus Rim 1.49 1.24 – 1.80 b0.00001 b0.00001
versus Surface 1.72 1.50 – 1.99 b0.00001 b0.00001
versus Surface 1.15 1.00 – 1.31 0.047 0.28
versus Buried 0.51 1.45 – 0.59 b0.00001 b0.00001
OR 95% C.I. p-Value Adjusted
p value
d versus Surface 0.64 0.58 – 0.73 b0.00001 b0.00001
versus Buried 0.98 0.75 – 1.27 0.88
versus Rim 0.65 0.87 – 0.49 0.003 0.018
versus Surface 0.63 0.49 – 0.81 0.0002 0.001
versus Surface 0.96 0.82 – 1.13 0.65
versus Buried 1.50 1.25 – 1.79 0.016 0.096
dds ratio; 95%CI, 95% confidence intervals; p-value, uncorrected
-interacting protein surface.
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Fig. 2. Distribution of the percentages of BLOSUM62, Grantham and SIFT scores for 3282 disease-causing SAVs and
1699 polymorphisms according to their location in different protein regions. Substitutions were characterized as
“damaging” according to the following parameters: Grantham score N 60, BLOSUM62 score b 0 and SIFT score ≤ 0.10.
*, Bonferroni-corrected p value of b0.05 ; **, Bonferroni-corrected p value of b0.01.
2889Missense Mutations and Protein–Protein Interfacesmay be sufficient to alter protein stability and function.
Thus, a more substantial change in the properties of a
residue at the non-interacting surface will generally be
required to cause an alteration of protein biological
activities. When BLOSUM62 and Grantham matrices
were used to analyze polymorphisms, the majority of
SAVs had scores suggestive of a “tolerant” nature. No
significant difference in score distributionwas observed
across the four protein regions when BLOSUM62 and
Grantham scores indicative of radical changes were
used (a score less than or equal to −2 for BLOSUM62
and greater than 100 for Grantham).
When disease-causing SAVs were analyzed
using SIFT, the number of SAVs identified as
deleterious was significantly greater for disease-
causing SAVs located in the buried region com-
pared to disease-causing SAVs in other regions,
whereas the number of deleterious SAV identified
as tolerant was significantly greater for disease-
causing SAVs located in non-interacting surface
compared to disease-causing SAVs in the other
regions (Bonferroni-corrected p b 0.01, χ2 test;
Fig. 2). The distribution of SIFT scores for
polymorphisms was similar, with a significantly
greater number of disease-causing SAVs predictedas damaging when located in buried residues
compared to surface and interface rim residues
(Bonferroni-corrected p b 0.01, χ2 test; Fig. 2).
SIFT, similarly to other heavily used prediction
programs, scores substitution using position-
specific information obtained from the alignment
of homologous proteins, as functionally and struc-
turally important amino acids are under evolution-
ary constraint, especially within a single protein
family. The less evolutionarily conserved nature of
residues in interface rim and non-interacting
surface compared to residues in buried and
interface core regions may explain why deleterious
substitutions in these regions were less likely to be
correctly predicted by programs such as SIFT,
which rely heavily on sequence conservation
among homologues.
Amino acid mutability varies across different
protein regions
Available prediction methods have been shown to
have different sensitivities in predicting the deleteri-
ous effect of substitutions at individual amino acid
levels [20]. Arginine and glycine are the most
Buried 
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Fig. 3. Amino acid susceptibility to disease-causing SAVs or polymorphisms according to structural location. The percentages of disease-causing SAVs (striped
boxes) and polymorphisms (uniform dark-gray boxes) harbored by each amino acid across the entire protein (“All”) and within the four structural regions of the protein,
that is, buried (Buried), interface core (Core), interface rim (Rim) and non-interacting surface (Surface), are shown.
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2891Missense Mutations and Protein–Protein Interfacesimportant contributors to disease [21–24]. Neverthe-
less, arginine and glycine are not among the top
three amino acids for which widely used prediction
servers exhibit the highest prediction sensitivity [20].
We determined whether the structural localization of
amino acid could add information in terms of
predicting the effect of SAVs.
Disease-causing SAV and polymorphism frequen-
cies for each of the 20 amino acids were analyzed
according to their location in the whole protein
sequence and in the four structural regions (Fig. 3).
Although individual amino acid susceptibility to
harbor a deleterious SAV or a polymorphism varied
across different protein regions, Arg, Gly and Trp
harbored more disease-causing SAVs than poly-
morphisms, whereas the opposite was true for Val
and Ile, Glu, Lys and Thr (Supplementary Tables 1
and 2).
In our dataset, Arg and Gly contributed 29% of all
disease-causing mutations and 20% of all polymor-
phisms, which is in accordance with previous finding
[25]. Mutations in codons encoding Arg result in
substitution of Arg with amino acids with very
different chemical characteristics. A recent study
by Petukh et al. looking at the most frequent
disease-causing mutations showed that a substan-
tial proportion involved a change from Arg to Cys,
Pro or Trp [21]. Among the most frequent harmful
amino acid substitutions were also changes from Gly
to Arg, Asp, Glu and Val [25]. Glycine is the smallest
of the 20 amino acids and its substitution with any
other residue is likely to have a major impact on
protein structure. Trp has an important, quite
specialized structural and functional role, such as
stacking interactions, and its replacement is poorly
tolerated. Moreover, because of its large size,
substitutions of Trp are likely to generate large
cavities in protein structure, which can compromise
protein stability, as well as affect PPIs.
Since arginine is an important contributor to
human disease [23], we explored the effect of
arginine substitutions in the four different protein
regions. As expected, arginine was the most
mutable amino acid (4.1% of all arginines in the
dataset harbored a disease-causing SAV and 1.8%Table 2. Disease-causing SAVs distribution according to ener
Total residues Observ
ΔΔGWT ≥ 1 kcal/mol 366 171
ΔΔGWT b 1 kcal/mol 29,704 11,569
Total 30,070 11,740
ΔΔGWT ≥ 2 kcal/mol 366 72
ΔΔGWT b 2 kcal/mol 29,704 4627
Total 30,070 4699
Residues with predictedΔΔGWT ≥ 2 kcal/mol (calculated with alanine s
spots.harbored a polymorphism) and the main contributor
to disease-causing SAVs (529 disease-causing
SAVs were arginine substitutions, 16.1% of all
disease-causing SAVs). Nevertheless, when struc-
tural regions were analyzed separately, arginine
substitutions were the main contributors to disease
in all but the buried region. Glycine substitutions
were the main contributors to disease in the buried
region, which can be explained as this region is
under spatial constrain and substitution of glycine is
likely to result in steric clashes. This is particularly
true when considering that the most harmful glycine
changes include substitutions with large amino
acids, such as Arg, Asp and Glu [25].
When we examined the percentage of substitu-
tions relative to each individual amino acid across
the different regions (Supplementary Table 1), a
disease-causing SAV was harbored by 11.1% of
buried and by 7.2% of interface core arginine
residues. These frequencies were well above the
median across all amino acids for each region
(buried amino acids, median of 2.38 and range of
11.1–1.0; interface core amino acids, median of 1.7
and range of 7.2–0.5) and vastly higher than what was
observed for arginine harboring disease-causing
SAVs located in interface rim and non-interacting
surface residues (2.8% and 3.5%, respectively).
Moreover, the disease-causing versus polymorphism
ratio was 8.1, 11.7, 1.9 and 1.76 for arginine
substitutions occurring in buried, interface core,
interface rim and non-interacting surface, respective-
ly, thus reflecting the important structural and func-
tional role of arginine in interface core and buried
regions, compared to the remaining protein structure.
Arginine structural role in proteins includes formation
of salt bridges and hydrogen bonds, alteration of
which has been shown to occur more in harmful than
harmless amino acid changes [3,25].
SAV characteristics vary across different
protein regions
We next evaluated the physicochemical changes
introduced by SAVs in terms of hydrophobicity, loss
of charge or polarity and charge change (Fig. 4).gy contribution of interface residues ΔΔGWT
ed Expected O/E p Value
142.89 1.20 0.002
11,597.11 1.00
58.40 1.23 0.0508
4739.60 0.98
canningmutagenesis, using FoldX) were considered energetic hot
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Fig. 4. Distribution of
the physicochemical
changes introduced by
SAVs. Changeswere eval-
uated in terms of hydro-
phobici ty, charge or
polarity loss and charge
changeacross the different
protein regions and overall
(All). Data were analyzed
for disease-causing SAVs
and polymorphisms. D,
disease-causing SAVs; P,
polymorphisms. Surface,
non-interacting surface.
2892 Missense Mutations and Protein–Protein InterfacesDisease-causing SAVs resulted in a major change in
69.0% of all cases, which, unsurprisingly, was a
significantly higher proportion (p b 0.01) compared
to polymorphisms (major change observed in 62.1%
of cases). This was in agreement with a recent study,
which showed that the less harmful amino acid
changes are those that introduce minimal changes in
the physicochemical characteristics of the residue
[25]. Moreover, we found that the distribution of
physicochemical changes was significantly different
between disease-causing SAVs and polymor-
phisms, overall (p b 0.01) and according to specific
protein region (p b 0.01). Overall, significantly more
disease-causing SAVs resulted in a loss of hydro-
phobicity (p = 0.045) and significantly fewer disease-
causing SAVs resulted in a change in charge,
compared to polymorphisms (p b 0.01).
Data were subsequently analyzed in relation to the
location of SAVs on the protein. A significant
difference in the distribution of change types across
the four protein regions was present (p b 0.01),
reflecting the different structural and functional role
of amino acids in individual regions. SAVs causing
hydrophobicity loss weremore likely to occur in buried
residues (462 out of 807) than in other regions of the
protein (p b 0.01), which reflects the importance of
hydrophobicity in driving correct protein folding. Loss
of hydrophobicity in buried amino acids is a well-
known cause of protein misfolding and early degra-
dation [26]. SAVs causing loss of charge or a change
in charge (frompositive to negativeor vice versa)were
more likely to occur in the non-interacting surface and
interface rim, whereas SAVs causing loss of polarity
were more frequent in the interface core compared to
the remaining regions. Electrostatic interactions are
the driving force of PPIs and introduction of mutations
altering the side-chain polarity and charge can
profoundly affect complex stability.
We did not examine the distribution of SAVs in
relation to their location in secondary structure
elements (SSE). Nevertheless, a recent study thatcorrelated the degree of harmfulness of naturally
occurring amino changes to their location according to
SSE showed that neutral and deleterious SAVs were
equally distributed among SSE. The authors conclud-
ed that SSE location was not useful for the prediction
of the deleterious effect of SAV, whereas the type of
amino change was more informative [25]. This is in
agreement with our results, which underlined the
importance of analyzing the location (e.g., interface
versus non-interacting surface) and type of change
introduced by SAVs (e.g., changes in the amino acid
chargeor in the ability to formsalt bridges compared to
wild type) when predicting the deleterious effect of
mutations.
Interface hot spots tend to be enriched in
disease-causing SAVs
The energetic contribution to protein complex
stability is not uniform across the interface but is
generally provided by a small subset of energetically
important “hot spot” residues [14,27]. In order to
address whether hot spots are enriched in disease-
causing SAVs, we first predicted the contribution of
interface residues to the binding free energy of
protein–protein complexes. This was achieved by
performing alanine scanning mutagenesis on the
interface residues of 2298 PPIs in our dataset. The
energy distribution across interface residues, clas-
s i f ied as core and r im, is presented in
Supplementary Fig. 1. Interface core residues
contributed significantly more than rim residues to
the binding free energy of the complex, regardless of
the threshold used. In particular, 42.5% of interface
core residues versus 23.2% of interface rim residues
had ΔΔGWT ≥ 1 kcal/mol (p b 0.001, χ2 test) and
20.3% versus 8.9% had ΔΔGWT ≥ 2 kcal/mol (hot
spot residues, p b 0.001, χ2 test).
Subsequently, we examined the energetic change
introduced by mutations. Energy data were predict-
ed for 366 disease-causing SAVs and 187
2893Missense Mutations and Protein–Protein Interfacespolymorphisms located at interface core and rim
residues. Disease-causing SAVs occurred preferen-
tially in interface residues with ΔΔGWT ≥ 1 kcal/mol
rather than b1 kcal/mol (p b 0.002) (Table 2). Within
different energetic classes, SAVs occurred more
often in core rather than rim residues (p b 0.01).
Moreover, a trend was observed (p = 0.0508) for
disease-causing SAVs to occur in hot spots
(ΔΔGWT ≥ 2 kcal/mol), regardless of their localiza-
tion in core or rim residues (Table 2). Although our
results did not reach statistical significance, possibly
because of the small number of observations,
interface hot spots appear to be important contrib-
utors to human disease. When polymorphisms were
analyzed, no preferential location in interface residues
with ΔΔGWT ≥ 1 kcal/mol rather than b1 kcal/mol
was found.
Next, we examined the energetic changes intro-
duced by SAVs. Disease-causing SAVs destabilizing
the protein–protein complex (ΔΔGMUT ≥ 2 kcal/mol)
were preferentially located in hot spot residues
(ΔΔGWT ≥ 2 kcal/mol, p b 0.001), whereas disease-
causing SAVs causing a modest or no change in
binding free energy (ΔΔGMUT b 1 kcal/mol,
p b 0.001) were preferentially located in energetically
less important residues, and this was independent
from residue location (interface core versus rim, p =
0.07). Similar results were obtained for polymor-
phisms. As the presence of structures generated by
homology modeling in our dataset may have biased
the accuracy of energy prediction, the abovemen-
tioned analyses were repeated using data available
from experimentally solved human structures only,
confirming our results (Supplementary Tables 3 and 4).
In our dataset, 17 polymorphisms (9 in interface core
and 8 in the rim) were predicted to cause a major
change in binding free energy (ΔΔGMUT ≥ 2 kcal/mol).
Since this was an unexpected finding, the phenotypes
associated with these 17 polymorphisms were ana-
lyzed in detail and results are presented in Supple-
mentary Table 5. Twelve of seventeen polymorphisms
were located in energetic hot spots. Minor allele
frequency data were available for seven polymor-
phisms and were indicative of a rare polymorphism
(minor allele frequency of b0.05) in three cases.
Phenotypic data were available for 3 of 17 polymor-
phisms. Two SAVs were reported to be associated
with a reduction in protein function and one SAV had
no effect at protein level. The paucity of experimental
data does not allow us to exclude that the remaining 14
polymorphisms,which are predicted to have an impact
onprotein complex stability,mayhaveasubtle effect at
phenotype level, alone or in combination with other
SAVs, such as the case of p.Pro11Leu (dbSNP:
rs34116584) in the serine pyruvate aminotransferase
(SPT; UniProt: P21549). This common polymorphism
is a Pro-to-Leu substitution at the interface rim of the
SPT homodimer. It creates a new mitochondrial
binding site, which is hidden and, thus, inefficient inthe normally tightly folded homodimer. Nevertheless,
in approximately 5% of cases, the SPT protein can
translocate to the mitochondria [28], thus suggesting
that p.Pro11Leu can have a subtle destabilizing effect
on the homodimer.
We next examined whether the energy contribu-
tion of the wild-type residue (ΔΔGWT) may help
predict the nature of the SAV. We found that the
ΔΔGWT was a poor predictor of the nature of SAVs
(polymorphism or disease-causing) and significantly
underperformed compared to SIFT and two predic-
tion servers Polyphen2 [29] and SuSPect [30], as
assessed by ROC analysis (data not shown).
Examples of the biological impact of SAVs
occurring at the interface rim
In our study, 257 (7.7%) disease-causing muta-
tions and 175 (10.3%) polymorphisms occurred in
the interface rim. The following are examples of the
biological impact of SAVs occurring in this structural
location, which is historically considered less impor-
tant than the interface core.
The deleterious mutation p.Glu63Lys has been
identified in the GTPase HRas protein (UniProt:
P01112) of patients with Costello syndrome (MIM:
218040) [31]. The latter is characterized by several
severe congenital abnormalities, which range from
mental retardation to cardiac malformations.
GTPases of the RAS family are important regulators
of the 1-phosphatidylinositol 4,5-bisphosphate phos-
phodiesterase epsilon-1 (PLCE1; UniProt: Q9P212).
Activation of the latter triggers an intracellular
cascade, ultimately leading to cell growth and
differentiation. Glutamic acid at position 63 (Glu63)
in the GTPase HRas protein is highly conserved, is
not predicted to be an energetic hot spot and is
located at the interface rim between proteins
GTPase HRas and PLCE1 (Fig. 5a). Glu-to-Lys
substitution is predicted to be damaging by SAV
prediction servers (Polyphen2 score = 0.983, SuS-
Pect score = 98, SIFT score = 0.00). Our structural
analysis reveals that substitution of the negatively
charged Glu with the positively charged Lys is
predicted to abolish the formation of a salt bridge
with Lys located on protein PLCE1, thus potentially
destabilizing the interaction between these two
proteins.
Polymorphism p.Arg115Trp (dbSNP: rs201053197)
occurs in acetyl serotonin O-methyltransferase
(ASMT; UniProt: P46597), an enzyme involved in the
synthesis of melatonin. Amino acid substitutions in this
enzyme are a known risk factor for the development of
autism [32]. Low melatonin levels are reported in
autistic patients and are associated with a reduction in
ASMT activity in patients with ASMT variations [32].
p.Arg115Trp is a rare polymorphism identified in
autistic patients [33]. Arg115 is located at the rim of
the large ASMT homodimerization interface (Fig. 5b).
Lys Glu 
2.9 
(a)
Arg 
Arg 
(b)
Fig. 5. Interface rim SAVs associated with disease. (a) Mutation p.Glu63Lys. The wild-type glutamic acid 63 located at
the interface rim of the GTPase HRAS protein is presented in blue and the interacting lysine on protein PLCE1 is presented
in magenta (PDB ID: 2c5l). (b) Polymorphism p.Arg115Trp (dbSNP: rs201053197). The water-mediated interaction
between wild-type arginines 115 at the ASMT homodimer interface is shown. Interacting arginines are presented in
magenta and water molecules are presented as blue spheres (PDB ID: 4a6d). The two chains of the interacting proteins
are presented in green and gray in both cases. Distances between atoms of two interacting residues are calculated in
angstroms (Å).
2894 Missense Mutations and Protein–Protein InterfacesArg115 is not predicted to be an energetic hot spot
and its substitution to Trp is predicted benign
(Polyphen2 score = 0.235, SuSPect score = 14,
SIFT score = 0.18). Arg115 is not conserved across
homologous proteins. Nevertheless, it is difficult to
assess the contribution of evolutionary conservation
to disease prediction when dealing with disorders
such as autism, for which no animal model exists.
We performed a structural analysis, which showed
that Arg-to-Trp substitution can abolish a water-
mediated polar interaction between Arg115 on the
two ASMT chains, as well as generate a steric clash,
thus potentially resulting in a less favorable interac-
tion and impaired protein function. This highlights
that a detailed structural analysis can have a central
role in the identification of SAVs that are likely to be
disease-causing variants.Discussion
Extensive analysis of interface residues in a large
dataset of protein–protein complexes allowed us to
demonstrate that disease-causing SAVs occur
significantly more often in the interface core rather
than in the rim, whereas the opposite is true for
polymorphisms. The interface core is considered to
be instrumental in establishing the affinity and
stability of PPI [17]. Because of their highly
specialized functional and structural role, interface
core residues, similarly to residues in the hydropho-
bic buried protein region, tend to be evolutionarily
conserved among homologous proteins, and amino
acid substitutions in these regions are less likely to
be tolerated compared to those occurring in the
interface rim and non-interacting surface.Studies have shown that disease-causing amino
acid changes are found mostly in buried and
interface core residues [1,25]. Although our study
shows that the interface rim and non-interacting
surface regions are not enriched in deleterious
SAVs, their contribution to disease is not to be
underestimated. In our dataset, more than one half
of disease-causing SAVs occurred in these two
regions, in agreement with previous reports [34].
This underlines the importance of correctly predict-
ing deleterious mutations occurring in these protein
areas. The interface rim and non-interacting surface
are generally less conserved from an evolutionary
point of view compared to the remainder of the
protein structure and can generally accommodate
larger substitutions in terms of physicochemical
changes, as shown by our results using BLOSUM62
and Grantham matrices. This can explain the lower
sensitivity of SIFT and other widely used prediction
servers in predicting the deleterious effect of
substitutions occurring in solvent-exposed residues,
compared to buried residues [20,35]. The ability to
computationally discriminate between neutral and
deleterious variants can greatly aid in prioritizing
candidate SAVs for additional studies and can
contribute in improving SAV prediction programs.
Structural data can provide important information
and help establish the phenotypic impact of amino
acid substitutions occurring in solvent-accessible
areas, such as the non-interacting surface and
interface rim.
In our study, arginine substitutions were 16.2% of
all disease-causing mutations, which is similar to
what has been previously reported (19%) [23].
Arginine is the most mutable amino acid [23] and
its substitutions account for a large proportion of the
2895Missense Mutations and Protein–Protein Interfacesmost harmful mutations [25]. Our results suggest
that its substitutions are likely to be deleterious and
this was particularly true for arginine residues
located in buried or interface core regions. In these
regions, the disease-to-neutral SAV ratio for arginine
substitutions was 1:8 and 1:5, respectively, whereas
the ratio was less than 2:1 in the non-interacting
surface and interface rim. Arginine can form salt
bridges and hydrogen bonds, which play the critical
role of stabilizing monomeric protein structures, as
well as protein–protein complexes [3,36]. Because
of this important structural role, arginine substitutions
in interface core and buried amino acids are hardly
ever tolerated and are likely to have a profound
impact on phenotype, as suggested by a recent
study, which showed that more than 60% of the most
harmful amino acid changes (the majority of which
were arginine substitutions) disrupted hydrogen
bonds formed by the wild-type amino acids [25].
It hasbeen suggested that protein–protein interfaces
should, generally, be energetically optimized to favor
complex formation [37] and the negative effect of
interface SAVs on the binding energy of protein
complexes has been demonstrated for mutations
causing diseases, such as glioblastoma [3,4]. A recent
analysis of the effect of a large set of experimentally
generated amino acid changes obtained from Skempi
and ProTherm databases showed that random amino
acid changes can destabilize the binding free energy of
these engineered proteins. Moreover, the energetic
change, although moderate on average, can become
major (≥2 kcal/mol) for specific amino acid changes
[25]. The authors showed that, for randomly placed
amino acid changes, the largest energetic changewas
produced by hydrophobic-to-charged or hydrophobic-
to-polar substitutions. Interestingly, our results showed
that hydrophobic substitutions are not predominant in
protein interfaces. This reinforces the concept that the
deleterious effect of an amino acid substitution should
be investigated, taking into account the structural
context in which the mutation occurs, not just the type
of amino acid change introduced.
Energetic hot spots are the major contributors to
the binding free energy of protein complexes. When
we examined their contribution to human disease,
we found that they are enriched in disease-causing
substitutions compared to less energetically impor-
tant interface residues. Nevertheless, our results did
not reach the threshold of statistical significance,
possibly because of the paucity of data and, thus,
need to be confirmed on a larger set of protein
interfaces.
Early work on five protein complexes reported in
ASEdb suggested that mutations in the interface rim
are silent or moderately affect the binding energy of
the complex (ΔΔG b 2 kcal/mol), whereas mutations
with the most deleterious effect on binding energy
(N2 kcal/mol) occur mainly in interface core residues
[38]. A recently published study, which was con-ducted in parallel to ours, analyzed the effect of the
binding and folding energies of a large set of
experimentally generated amino acid changes oc-
curring in interface core, rim and support, as well as
in the buried (interior) and surface protein regions.
The authors showed that the probability of an amino
acid substitution to cause a large change in binding
free energy (Pp index) more than doubles when the
change occurs in a core residue compared to a rim
residue [25]. Our results confirm that the interface
core provides the majority of hot spots and is
enriched in disease-causing SAVs, but they also
suggest that minority of rim residues are important
contributors to the binding free energy of the
complex and substitutions occurring at these posi-
tions are not always energetically silent.
One limitation of our study is that we did not
assess whether our findings are influenced by the
transient or permanent nature of the protein com-
plex, as this would require that proteins were
systematically assigned to these two groups, a
task that is not trivial. A second limitation of our
study could be the use of a single program to predict
the energetic effect of SAVs. Although we could
have verified our results by implementing other
energy prediction programs, a recent study showed
that combining results obtained using different
methods does not significantly improve the results
obtained from individual methods [39].
The use of structural data allowed us to perform an
in-depth analysis of the mechanisms by which SAVs
can affect protein function. Such information, which
cannot be derived by current SAV prediction
methods, can help to screen for deleterious SAVs,
especially in the presence of contradictory results
from different prediction programs. Determining the
structure–function relationship of PPIs and the
impact of SAVs occurring at interfaces is crucial to
understand how deleterious mutations and rare
polymorphisms can affect biological pathways and
can provide a better understanding of the genotype–
phenotype relationship.Materials and Methods
Datasets
Human SAVs data were retrieved from UniProt (humsa-
var.txt, release 23_10) [40]. Each SAV in humsavar is
classified as “disease” (SAVwith knowndisease association),
“polymorphism” (SAV with no known disease association)
and “unclassified” (SAV with too little information to be
classified). Unclassified SAVs were not included in the
analysis, as their nature remains uncertain.
Human PPI data and protein complexes structural data
were retrieved from Interactome3D [41]. Human protein
interaction data in this database are derived from
experimentally documented human interactions, listed in
2896 Missense Mutations and Protein–Protein Interfacesnine major interaction databases. Additional human PPIs
are inferred from experimental data observed in orthologous
proteins. Interactome3D provides structural data for human
PPIs that are derived from the Protein DataBank (PDB) [42].
In the absence of an experimental structure for the human
complex, structures are derived from homologous com-
plexes [41]. To ensure that all models for complexes were
reliable, we required that the sequence identity between the
homologue in PDB and UniProt was ≥30%. In addition,
SAVs analysis was only performed on proteins for which at
least 80%of theUniProt sequencewas covered by thePDB.
Calculation of protein interfaces, relative solvent-
accessible area and binding free energy
Residues were assigned to interface when the distance
between at least one atom on two different interacting
proteins was within 5 Å. The percentage relative solvent-
accessible area of each amino acid was calculated by
dividing its total surface area with that in the extended
conformation (ф = Ψ = 180°) of the Gly–X–Gly tripeptide.
Residues were defined as “buried” or “solvent-accessible”
residues according to relative solvent-accessible area,
using a cutoff of 7% [43]. Interface residueswere segregated
in core and rim according to their solvent accessibility in the
bound state. Residues were defined as core when they
became buried uponPPI andwere defined as rimwhen they
remained partially exposed [15] (illustrated in Fig. 1).
For each interface residue, the contribution to the binding
free energy of the protein complex was calculated using the
FoldX algorithm [44]. Initially, all PDB files were repaired (as
recommended by the FoldX protocol) using the RepairPDB
built-in function in FoldX, which corrects poor torsion angles
and van der Waals clashes, when present. Thereafter, all
interface residues in each complex were sequentially
mutated to alanine (alanine scanning mutagenesis) and the
energetic contribution of each wild-type residue (ΔΔGWT)
was calculated as the difference between the contribution of
alanine and that of the wild-type residue, expressed in
kilocalories per mole (kcal/mol). The contribution of each
interface residue to the binding free energy of the complex
was classified as follows: (1) minor contribution when
0.5 kcal/mol ≤ ΔΔGWT b 1 kcal/mol; (2) moderate contri-
bution (“warm residues”) when 1 kcal/mol ≤ ΔΔGWT b
2 kcal/mol [45]; and (3) major contribution (energetic hot
spot residue) when ΔΔGWT ≥ 2 kcal/mol [14]. Calculation
of the impact of interface SAVs on the binding free energy
of the complex (ΔΔGMUT) was performed using FoldX.
FoldX has a reported correlation of 0.81 with an SD (FoldX
accuracy) of 0.46 kcal/mol between calculated and
experimental ΔΔG values when calibrated using the
experimentally determined mutational free energy chang-
es of more than 1000 SAVs [44]. FoldX was chosen
among other prediction programs because it is easy to use
and one of the best prediction programs to evaluate the
energetic impact of SAVs [39]. In order to study the effect
of SAVs, all repaired PDB structures were mutated using
the BuildModel function in FoldX. The algorithm was run
several times for each specified mutation using the option
“bnumberOfRunsN5” to optimize the minimum energy
conformation of residues with multiple rotamers. The
ΔΔGMUT was calculated as the difference between the
binding free energy of the mutant complex and that of the
wild type.Prediction of the effect of SAVs
Three in silico sequence-based methods were applied
for predicting the effect of each SAV on protein structure
and function:
(1) BLOSUM62 matrix [46]: this method calculates the
substitution frequency for all amino acid pairs, based
on multiple sequence alignment. A positive score of
≥0 is indicativeof aconservativesubstitution,whereas
anegative score of less than or equal to−1 indicated a
non-conservative substitution, hence a potentially
deleterious SAV. “Radical” changes were those with
a score of less than or equal to −2.
(2) Grantham matrix [47]: this method classifies amino
acid changes into classes of increasing physicochem-
ical dissimilarity. In particular, it scores an amino acid
substitution based on side-chain atomic composition,
polarity and volume. It measures variations in terms of
difference in side-chain atomic composition, polarity
and volume between two amino acids. Changes were
considered “conservative” for scores 0–60 and
“non-conservative” when more than 60. Radical
changes were considered those with a score of N100.
(3) SIFT (Sorting Tolerant From Intolerant) [48]: this
method predicts the functional impact of a residue
change based on position-specific information
(position-specific scoring matrices) obtained from
the alignment of homologous proteins. Score
ranges from 0 to 1. Scores were classified as
“intolerant”when ≤0.10 and “tolerant”when N0.10.
Amino acid classification
Amino acids were divided into the following four groups
according to their physicochemical properties: polar (Gln,
Asn, His, Ser, Thr, Tyr, Cys, Met and Trp), hydrophobic (Ala,
Ile, Leu, Phe, Val, Pro and Gly) and charged (Arg, Lys, Asp
and Glu). Residues in the latter group were also divided in
positively (Arg and Lys) and negatively charged (Asp and
Glu). Although other amino acid classifications could have
used (e.g., according to size), this simple classification was
used as it allows classifying all amino acids without resulting
in amino acid overlap between classes.Statistical analysis
All statistical analyses were performed using the
statistical packages in R version 3.1.1. The likelihood of
a disease-causing or polymorphism SAV residing in a
specific region i rather that region j was expressed in terms
of odds for each region (probability of the SAV residing in
the region divided by the probability that it does not reside
in the region) and comparison between regions made by
means of odds ratia: ORij = (xi/(1 − xi))/(xj/(1 − xj)), where
xi is the probability of observing a SAV in region i.
The chi-square test was used to compare the observed
number of SAVs in each region to the expected if SAVs
were distributed according to the number of residues in the
different regions. A two-tailed p value less than 0.05 was
considered indicative of statistical significance. Bonferroni
correction was used to correct for multiple comparisons.
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